Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors
Authors
Keywords
-
Journal
BMC CANCER
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-19
DOI
10.1186/s12885-020-06928-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer
- (2019) Jingxuan Fu et al. Radiation Oncology
- Adjuvant Chemoradiation Therapy for Cervical Cancer and Effect of Timing and Duration on Treatment Outcome
- (2017) Sachin Jhawar et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence
- (2016) Michela Salvatici et al. GYNECOLOGIC ONCOLOGY
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pretreatment Factors Associated with Recurrence for Patients with Cervical Cancer International Federation of Gynecology and Obstetrics Stage IB1 Disease
- (2015) Shih-Chieh Liu et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease
- (2015) Beata Kotowicz et al. TUMOR BIOLOGY
- Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice
- (2013) Kotaro Shimura et al. Journal of Gynecologic Oncology
- Prognostic Value of Different Patterns of Squamous Cell Carcinoma Antigen Level for the Recurrent Cervical Cancer
- (2013) Bae Kwon Jeong et al. Cancer Research and Treatment
- Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix
- (2012) Eng-Yen Huang et al. Radiation Oncology
- Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma
- (2011) Kenji Hashimoto et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- A validation study of new risk grouping criteria for postoperative treatment in stage IB cervical cancers without high-risk factors: Rethinking the Gynecologic Oncology Group criteria
- (2009) Suk-Joon Chang et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer
- (2008) Jonas van de Lande et al. GYNECOLOGIC ONCOLOGY
- The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: A review of the literature
- (2007) Angiolo Gadducci et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Comparison of adjuvant chemotherapy and radiation in patients with intermediate risk factors after radical surgery in FIGO stage IB-IIA cervical cancer
- (2007) K.-B. LEE et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now